Similarly, Li et al. [59] implicated TMEFF2 in the development of drug resistance in ovarian cancer cells through its positive regulation by the long noncoding RNA TMPO-AS1 (TMPO-AS1 ⟞ miR-200c ⟞ TMEFF2). This evidence concerns the gene TMPO and ovarian cancer.